Showing results (71-80 of 1,988) with videos related to

Sort By:
Pageof 199
Prostate Cancer and Prostatic Diseases|March 22, 2021
Aberrations in circulating ceramide levels are associated with poor clinical outcomes across localised and metastatic prostate cancerHui-Ming Lin, Kevin Huynh, Manish Kohli, et al.
Prostate Cancer and Prostatic Diseases|July 27, 2011
Quadriplex model enhances urine-based detection of prostate cancerT Jamaspishvili, M Kral, I Khomeriki, et al.
Prostate Cancer and Prostatic Diseases|June 1, 2011
Inhibitory member of the apoptosis-stimulating protein of p53 (ASPP) family promotes growth and tumorigenesis in human p53-deficient prostate cancer cellsB Zhang, H J Xiao, J Chen, et al.
Prostate Cancer and Prostatic Diseases|May 18, 2011
Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancerE S Antonarakis, A J Armstrong
Prostate Cancer and Prostatic Diseases|May 4, 2011
Outcomes of extremely low risk prostate cancer following radical prostatectomyE W Lee, J Laze, H Lepor
Prostate Cancer and Prostatic Diseases|March 30, 2011
Hot flushes in prostatic cancer patients during androgen-deprivation therapy with monthly dose of degarelix or leuprolideP Iversen, C Karup, E van der Meulen, et al.
Prostate Cancer and Prostatic Diseases|April 20, 2011
National-wide data on the treatment of BPH in KoreaJ Y Kang, G E Min, H Son, et al.
Prostate Cancer and Prostatic Diseases|October 12, 2011
Impact of pretreatment factors, biopsy Gleason grade volume indices and post-treatment nadir PSA on overall survival in patients with metastatic prostate cancer treated with step-up hormonal therapyS Miyamoto, K Ito, M Miyakubo, et al.
Prostate Cancer and Prostatic Diseases|December 7, 2011
Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy schemeM Nomura, K Ito, M Miyakubo, et al.
Prostate Cancer and Prostatic Diseases|December 7, 2011
Active surveillance for low-risk prostate cancer: knowledge, acceptance and practice among urologistsM A Gorin, A Eldefrawy, O Ekwenna, et al.
Pageof 199